Cost-Effectiveness of MODY Genetic Testing: Translating Genomic Advances Into Practical Health Applications

Patterns of Medication Initiation in Newly Diagnosed Diabetes Mellitus: Quality and Cost Implications

(2012) Nihar R. Desai et al.   AMERICAN JOURNAL OF MEDICINE

Systematic Assessment of Etiology in Adults With a Clinical Diagnosis of Young-Onset Type 2 Diabetes Is a Successful Strategy for Identifying Maturity-Onset Diabetes of the Young

(2012) G. Thanabalasingham et al.   DIABETES CARE

The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes

(2012) B. M. Shields et al.   DIABETOLOGIA

Urinary C-Peptide Creatinine Ratio Is a Practical Outpatient Tool for Identifying Hepatocyte Nuclear Factor 1- /Hepatocyte Nuclear Factor 4-  Maturity-Onset Diabetes of the Young From Long-Duration Type 1 Diabetes

(2011) R. E. J. Besser et al.   DIABETES CARE

A large multi-centre European study validates high-sensitivity C-reactive protein (hsCRP) as a clinical biomarker for the diagnosis of diabetes subtypes

(2011) G. Thanabalasingham et al.   DIABETOLOGIA

Clinical Characteristics and Diagnostic Criteria of Maturity-Onset Diabetes Of The Young (MODY) due to Molecular Anomalies of theHNF1AGene

(2011) Christine Bellanné-Chantelot et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Double Heterozygous Mutations Involving Both HNF1A/MODY3 and HNF4A/MODY1 Genes: A case report

(2010) G. Forlani et al.   DIABETES CARE

Maturity-onset diabetes of the young (MODY): how many cases are we missing?

(2010) B. M. Shields et al.   DIABETOLOGIA

Glucokinase diabetes in 103 families from a country-based study in the Czech Republic: geographically restricted distribution of two prevalent GCK mutations

(2010) Stepanka Pruhova et al.   PEDIATRIC DIABETES

Hepatocyte nuclear factor (HNF)1A and HNF4A substitution occurring simultaneously in a family with maturity-onset diabetes of the young

(2009) H. J. B. H. Beijers et al.   DIABETIC MEDICINE

A genetic diagnosis ofHNF1Adiabetes alters treatment and improves glycaemic control in the majority of insulin-treated patients

(2009) M. Shepherd et al.   DIABETIC MEDICINE

What Does the Value of Modern Medicine Say About the $50,000 per Quality-Adjusted Life-Year Decision Rule?

(2009) R Scott Braithwaite et al.   MEDICAL CARE

Mild fasting hyperglycemia in children: high rate of glucokinase mutations and some risk of developing type 1 diabetes mellitus

(2009) Ethel Codner et al.   PEDIATRIC DIABETES

National Trends in Treatment of Type 2 Diabetes Mellitus, 1994-2007

(2008) G. Caleb Alexander et al.   ARCHIVES OF INTERNAL MEDICINE

Long-Term Follow-Up of Oral Glucose Tolerance Test-Derived Glucose Tolerance and Insulin Secretion and Insulin Sensitivity Indexes in Subjects With Glucokinase Mutations (MODY2)

(2008) D. Martin et al.   DIABETES CARE

Clinical implications of a molecular genetic classification of monogenic β-cell diabetes

(2008) Rinki Murphy et al.   Nature clinical practice. Endocrinology & metabolism